Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
NCT00098046
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Chickenpox
Herpes Zoster
Interventions
DRUG:
famciclovir
Sponsor
Novartis